Diagnostic innovation and patient safety have dominated this year’s healthcare-focussed awards to mark European Laboratory ...

Private asset manager Capital Dynamics has invested €14m in Celsus Holding, the holding company through which private equity ...

Private asset manager Capital Dynamics has invested €14m in Celsus Holding, the holding company through which private equity ...

Medtronic has received CE Mark approval for its Vitalis portfolio of five pacemakers, including a device designed for ...

Sobi’s olezarsen (TRYNGOLZA) has received a positive opinion from the European Medicines Agency’s Committee for Medicinal ...

A pilot scheme in east London is offering cholesterol-lowering injections at community pharmacies to help patients access ...

AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has been approved by the European ...

Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence (AI) to investigate why ...

Onicor, a medical technology company developing a personalised treatment for onychomycosis (fungal nail infection), has ...

Researchers at Manchester Metropolitan University are investigating whether regular hot-water immersion can improve mobility ...

Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community ...

The Scottish Medicines Consortium (SMC) has accepted AbbVie’s Aquipta (atogepant) as an option for the acute treatment of ...